| Key Financial Ratios of Beta Drugs (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
42.02 |
37.90 |
31.95 |
25.82 |
12.20 |
|
| Diluted EPS (Rs.) |
42.02 |
37.90 |
31.95 |
25.82 |
12.20 |
|
| Cash EPS (Rs.) |
54.42 |
48.08 |
42.78 |
33.37 |
19.35 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
195.25 |
163.43 |
127.82 |
96.05 |
71.37 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
195.25 |
163.43 |
127.82 |
96.05 |
71.37 |
|
| Revenue from Operations/Share (Rs.) |
358.96 |
307.59 |
236.24 |
191.22 |
120.79 |
|
| PBDIT/Share (Rs.) |
80.28 |
63.82 |
56.05 |
45.20 |
26.26 |
|
| PBIT/Share (Rs.) |
67.89 |
53.65 |
45.22 |
37.65 |
19.11 |
|
| PBT/Share (Rs.) |
56.44 |
50.71 |
42.71 |
35.68 |
16.59 |
|
| Net Profit/Share (Rs.) |
42.02 |
37.90 |
31.95 |
25.82 |
12.20 |
|
| NP After MI And SOA / Share (Rs.) |
42.02 |
37.90 |
31.95 |
25.82 |
12.20 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
22.36 |
20.74 |
23.72 |
23.63 |
21.73 |
|
| PBIT Margin (%) |
18.91 |
17.44 |
19.14 |
19.69 |
15.81 |
|
| PBT Margin (%) |
15.72 |
16.48 |
18.07 |
18.65 |
13.73 |
|
| Net Profit Margin (%) |
11.70 |
12.32 |
13.52 |
13.50 |
10.09 |
|
| NP After MI And SOA Margin (%) |
11.70 |
12.32 |
13.52 |
13.50 |
10.09 |
|
| Return on Networth/Equity (%) |
21.52 |
23.19 |
24.99 |
26.88 |
17.08 |
|
| Return on Capital Employed (%) |
20.54 |
30.43 |
32.10 |
33.24 |
22.09 |
|
| Return on Assets (%) |
9.72 |
14.33 |
15.48 |
15.72 |
9.97 |
|
| Total Debt/Equity (X) |
0.67 |
0.07 |
0.13 |
0.18 |
0.21 |
|
| Asset Turnover Ratio (%) |
1.05 |
1.31 |
1.27 |
1.09 |
0.82 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
3.22 |
2.10 |
2.03 |
1.98 |
1.99 |
|
| Quick Ratio (X) |
2.64 |
1.51 |
1.54 |
1.52 |
1.53 |
|
| Inventory Turnover Ratio (X) |
3.21 |
4.17 |
4.16 |
5.70 |
4.47 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Coverage Ratios |
|
|
|
|
|
|
| Interest Coverage Ratios (%) |
11.60 |
21.76 |
22.31 |
22.88 |
10.43 |
|
| Interest Coverage Ratios (Post Tax) (%) |
11.60 |
21.76 |
22.31 |
22.88 |
10.43 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,909.20 |
1,168.47 |
599.62 |
542.92 |
119.61 |
|
| EV/Net Operating Revenue (X) |
5.27 |
3.95 |
2.64 |
2.95 |
1.03 |
|
| EV/EBITDA (X) |
23.56 |
19.04 |
11.13 |
12.49 |
4.74 |
|
| MarketCap/Net Operating Revenue (X) |
5.31 |
4.01 |
2.65 |
2.96 |
0.99 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
9.76 |
7.55 |
4.90 |
5.89 |
1.68 |
|
| Price/Net Operating Revenue |
5.31 |
4.01 |
2.65 |
2.96 |
0.99 |
|
| Earnings Yield |
0.02 |
0.03 |
0.05 |
0.05 |
0.10 |
|
Source : Dion Global Solutions Limited
